{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:30:45Z","timestamp":1755797445620},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/rlu.0000000000000824","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T11:49:07Z","timestamp":1432813747000},"page":"674-675","source":"Crossref","is-referenced-by-count":2,"title":["Foreign Body Abscess Mimicking a Malignant Peripheral Nerve Sheath Tumor in a Patient With Neurofibromatosis Type 1"],"prefix":"10.1097","volume":"40","author":[{"given":"Johannes","family":"Salamon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard E.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor F.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Derlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210204","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1.","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"R2-13-20210204","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jso.20971","article-title":"Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations.","volume":"97","author":"Grobmyer","year":"2008","journal-title":"J Surg Oncol"},{"key":"R3-13-20210204","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"R4-13-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W","article-title":"Plexiform neurofibromas.","volume":"89","author":"Korf","year":"1999","journal-title":"Am J Med Genet"},{"key":"R5-13-20210204","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"key":"R6-13-20210204","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00234-005-0033-4","article-title":"MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.","volume":"48","author":"Mautner","year":"2006","journal-title":"Neuroradiology"},{"key":"R7-13-20210204","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00432-008-0523-y","article-title":"Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.","volume":"135","author":"Matsumine","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"R8-13-20210204","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/RLU.0b013e3182a757d3","article-title":"Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.","volume":"39","author":"Urban","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R9-13-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/RLU.0b013e318266ce84","article-title":"Comparative effectiveness of 18F-FDG PETCT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.","volume":"38","author":"Derlin","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R10-13-20210204","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.rlu.0000129121.55248.f5","article-title":"Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.","volume":"29","author":"Chander","year":"2004","journal-title":"Clin Nucl Med"},{"key":"R11-13-20210204","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00259-012-2314-6","article-title":"Evaluation of intratumoural heterogeneity on 18F-FDG PETCT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.","volume":"40","author":"Salamon","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-13-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00330-013-3020-x","article-title":"18F-FDG PETCT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.","volume":"24","author":"Salamon","year":"2014","journal-title":"Eur Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:12:01Z","timestamp":1620972721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201508000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000824","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}